Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Medicus Pharma Ltd (MDCX) had Stock-Based Compensation of $0.60M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-9.25M |
|
-- |
|
-- |
|
$8.60M |
|
$-8.60M |
|
$-0.45M |
|
$-9.04M |
|
$-8.92M |
|
$-9.04M |
|
$-9.04M |
|
$-9.04M |
|
$-8.92M |
|
$-8.60M |
|
$-8.60M |
|
29.54M |
|
29.54M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$7.28M |
|
-- |
|
$0.14M |
|
$7.43M |
|
$5.95M |
|
-- |
|
$0.05M |
|
$6.00M |
|
$1.43M |
|
$1.43M |
|
$1.43M |
|
39.99M |
|
| Cash Flow Statement Financials | |
$-8.97M |
|
-- |
|
$6.83M |
|
$8.71M |
|
$6.37M |
|
$-2.34M |
|
|
Stock-Based Compensation |
$0.60M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.22 |
|
-- |
|
-- |
|
-- |
|
1.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-633.26% |
|
-633.26% |
|
-121.75% |
|
-633.26% |
|
$0.04 |
|
$-0.30 |
|
$-0.30 |
|